BeStock  

Solventum SOLV

US equityMarket cap rank #1138Medical Instruments & Supplies
$84.50 −$1.30 (-1.52%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $84.50 0.00%
Open$86.41
Prev close$85.80
Day range$84.13 – $87.11
Volume658.4K
Market cap$14.34B
P/E (TTM)94.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.95B-7.0% YoY
Operating profit$68.00M-60.5% YoY
Net profit-$12.00M-100.9% YoY
Diluted EPS-$0.07-101.0% YoY
Free cash flow$97.00M+561.9% YoY
Operating cash flow$177.00M

Revenue, last 8 quarters

$2.1BDec '24$2.1BMar '25$2.2BJun '25$2.1BSep '25$2.0BDec '25$2.0BMar '26$2.2BJun '26$1.9BSep '26

Net profit, last 8 quarters

$30.0MDec '24$137.0MMar '25$90.0MJun '25$1.3BSep '25$63.0MDec '25$13.0MMar '26$93.0MJun '26$-12.0MSep '26

Diluted EPS by quarter

0.17Dec '240.78Mar '250.51Jun '257.22Sep '250.36Dec '250.07Mar '260.53Jun '26-0.07Sep '26

Free cash flow by quarter

$92.0MDec '24$-80.0MMar '25$59.0MJun '25$-21.0MSep '25$32.0MDec '25$-273.0MMar '26$144.0MJun '26$97.0MSep '26

Annual revenue

$7.3BFY20$8.2BFY21$8.1BFY22$8.2BFY23$8.3BFY24$8.3BFY25

Profitability & balance sheet

Gross margin54.8%
Operating margin5.2%
Net margin1.9%
Return on equity3.2%
Return on assets1.1%
Return on invested capital3.7%
Current ratio1.03
Liabilities / assets66.1%
Cash & investments$451.00M
Total debt$5.27B
Net cash (debt)-$4.82B

Where the revenue comes from

Quarter 2026/Q3

By business line

  • MedSurg$1.21B 62.2%
  • Health Information Systems$356.00M 18.3%
  • Dental Solutions$317.00M 16.3%
  • All other$64.00M 3.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.95B $2.21B $2.01B $8.33B $2.00B
Total Operating Revenue $1.95B $2.21B $2.01B $8.33B $2.00B
Cost of Revenue $887.00M $923.00M $911.00M $3.87B $971.00M
Gross Profit $1.06B $1.29B $1.10B $4.45B $1.03B
Operating Expense $994.00M $1.11B $1.02B $3.82B $934.00M
Selling and Admin Expenses $813.00M $927.00M $827.00M $3.08B $759.00M
Research & Development $181.00M $178.00M $189.00M $739.00M $175.00M
Operating Profit $68.00M $181.00M $79.00M $632.00M $93.00M
Net Non-Operating Interest Income (Expense) -$68.00M -$64.00M -$62.00M -$347.00M -$51.00M
Non-Operating Interest Expense $68.00M $64.00M $62.00M $347.00M $51.00M
Other Income (Expense) -$10.00M -$9.00M -$4.00M $1.43B $16.00M
Special Income (Charges) $0.00 – – $1.47B $31.00M
-Gain on Sale Of Business $0.00 – – $1.55B $31.00M
Other Non-Operating Income (Expenses) -$10.00M -$9.00M -$4.00M -$39.00M -$15.00M
Pretax Profit -$11.00M $108.00M $16.00M $1.71B $58.00M
Tax $1.00M $15.00M $3.00M $157.00M -$5.00M
Net Profit -$12.00M $93.00M $13.00M $1.56B $63.00M
Profit from Continuing Operations -$12.00M $93.00M $13.00M $1.56B $63.00M
Net Income to Parent Company -$12.00M $92.00M $13.00M $1.56B $63.00M
Net Income to Common Stockholders -$12.00M $92.00M $13.00M $1.56B $63.00M
Basic EPS -$0.07 $0.53 $0.07 $8.94 $0.36
Diluted EPS -$0.07 $0.53 $0.07 $8.88 $0.36
-Less:Other Special Charges – – – $82.00M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $14.17B $14.24B $14.10B $14.29B $14.29B
Total Current Assets $3.69B $3.74B $3.58B $3.86B $3.86B
Cash and Cash Equivalents & Short-Term Investments $451.00M $403.00M $561.00M $878.00M $878.00M
-Cash and Cash Equivalents $451.00M $403.00M $561.00M $878.00M $878.00M
Receivables $1.39B $1.43B $1.18B $1.18B $1.18B
-Accounts Receivable $1.36B $1.31B $1.06B $1.03B $1.03B
-Due from Related Parties Current $27.00M $122.00M $121.00M $150.00M $150.00M
Prepaid Assets $206.00M $205.00M $187.00M $174.00M $174.00M
Inventory $1.10B $1.04B $1.09B $1.07B $1.07B
Other Current Assets $542.00M $661.00M $566.00M $557.00M $557.00M
Total Non-Current Assets $10.47B $10.50B $10.52B $10.44B $10.44B
Net PPE $1.78B $1.75B $1.73B $1.33B $1.33B
-Gross PPE $3.70B $3.64B $3.60B $3.19B $3.19B
-Accumulated Depreciation -$1.93B -$1.89B -$1.87B -$1.87B -$1.87B
Goodwill and Other Intangible Assets $7.93B $8.03B $8.12B $8.30B $8.30B
-Goodwill $5.62B $5.63B $5.63B $5.70B $5.70B
-Other Intangible Assets $2.32B $2.41B $2.50B $2.59B $2.59B
Non-Current Deferred Assets $380.00M $344.00M $303.00M – –
Other Non-Current Assets $384.00M $372.00M $359.00M $814.00M $814.00M
Total Liabilities $9.36B $9.44B $9.13B $9.24B $9.24B
Total Current Liabilities $3.58B $3.66B $3.35B $3.14B $3.14B
Payables $1.09B $1.21B $1.21B $1.32B $1.32B
-Accounts Payable $808.00M $701.00M $699.00M $687.00M $687.00M
-Total Tax Payable $131.00M $176.00M $170.00M $196.00M $196.00M
-Due to Related Parties Current $152.00M $331.00M $337.00M $435.00M $435.00M
Current Accrued Expenses $559.00M $295.00M $209.00M $243.00M $243.00M
Short-Term Debt and Capital Lease Obligation $507.00M $506.00M $505.00M – –
-Current Debt $507.00M $506.00M $505.00M – –
Current Deferred Liabilities $596.00M $596.00M $613.00M $621.00M $621.00M
Other Current Liabilities $563.00M $841.00M $646.00M $634.00M $634.00M
Total Non-Current Liabilities $5.79B $5.78B $5.78B $6.11B $6.11B
Long Term Debt and Capital Lease Obligation $4.77B $4.78B $4.78B $5.04B $5.04B
-Long Term Debt $4.56B $4.57B $4.58B $5.04B $5.04B
-Long Term Capital Lease Obligation $206.00M $207.00M $207.00M – –
Non-Current Deferred Liabilities $154.00M $157.00M $161.00M $164.00M $164.00M
Employee Benefits $355.00M $358.00M $360.00M $363.00M $363.00M
Other Non-Current Liabilities $509.00M $486.00M $478.00M $546.00M $546.00M
Total Equity $4.81B $4.80B $4.97B $5.05B $5.05B
Stockholders' Equity $4.81B $4.80B $4.97B $5.05B $5.05B
Capital Stock $2.00M $2.00M $2.00M $2.00M $2.00M
-Common Stock $2.00M $2.00M $2.00M $2.00M $2.00M
Additional Paid-In Capital $3.98B $3.92B $3.90B $3.88B $3.88B
Retained Earnings $1.89B $1.90B $1.81B $1.80B $1.80B
Less: Treasury Stock -$403.00M -$355.00M -$67.00M – –
Gains/Losses Not Affecting Retained Earnings -$667.00M -$669.00M -$670.00M -$625.00M -$625.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $177.00M $227.00M -$189.00M $369.00M $95.00M
Net cash flow from continuing operations $179.00M $224.00M -$188.00M $369.00M $95.00M
Net Income from Continuing Operations -$12.00M $92.00M $13.00M $1.56B $63.00M
Gain/Loss from Continuing Operations $13.00M $13.00M $14.00M -$1.49B -$18.00M
Depreciation & Depletion & Amortization $136.00M $133.00M $135.00M $489.00M $117.00M
Deferred Tax -$51.00M -$47.00M -$41.00M -$120.00M -$73.00M
Change in Working Capital $51.00M -$5.00M -$360.00M -$119.00M -$6.00M
-Change in Receivables $42.00M -$253.00M -$6.00M $78.00M $5.00M
-Change in Inventory -$60.00M $50.00M -$32.00M -$139.00M -$5.00M
-Change in Payables and Accrued Expense -$55.00M $36.00M -$228.00M $136.00M $53.00M
-Change In Other Working Capital $124.00M $162.00M -$94.00M -$194.00M -$59.00M
Net cash flow from investing -$80.00M -$87.00M -$77.00M $2.80B -$745.00M
Net Cash Flow from Continuing Investing Activities -$80.00M -$87.00M -$77.00M $2.80B -$745.00M
Net PPE Purchase and Sale -$80.00M -$83.00M -$84.00M -$379.00M -$63.00M
Net Other Investing Changes $0.00 -$4.00M $7.00M -$18.00M -$6.00M
Financing Cash Flow -$51.00M -$300.00M -$50.00M -$3.06B -$115.00M
Net Cash Flow from Continuing Financing Activities -$50.00M -$301.00M -$50.00M -$3.06B -$115.00M
Net Issuance Payments Of Debt $0.00 $0.00 $46.00M -$3.07B -$100.00M
Net Common Stock Issuance -$48.00M -$288.00M -$67.00M – –
Net Other Financing Charges -$3.00M -$12.00M -$29.00M $13.00M -$15.00M
Ending Cash Balance $451.00M $403.00M $561.00M $878.00M $878.00M
Net Change in Cash $48.00M -$161.00M -$315.00M $109.00M -$765.00M
Beginning Cash Balance $403.00M $561.00M $878.00M $762.00M $1.64B
Effect of Exchange Rate Changes $0.00 $3.00M -$2.00M $7.00M $1.00M
Free Cash Flow $97.00M $144.00M -$273.00M -$10.00M $32.00M
Other Non-Cash Items – $3.00M -$1.00M -$111.00M -$25.00M
Net Business Purchase and Sale – – – $3.19B -$676.00M

Discussion

No comments yet — be the first to weigh in on SOLV.

Sign in to join the discussion.

Scroll to Top